Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
2(6%)
Results Posted
36%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
4
13%
Ph phase_3
2
6%
Ph phase_2
8
26%
Ph phase_1
15
48%

Phase Distribution

15

Early Stage

8

Mid Stage

2

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
15(51.7%)
Phase 2Efficacy & side effects
8(27.6%)
Phase 3Large-scale testing
2(6.9%)
N/ANon-phased studies
4(13.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

2

trials recruiting

Total Trials

31

all time

Status Distribution
Active(3)
Completed(11)
Terminated(2)
Other(15)

Detailed Status

unknown15
Completed11
Recruiting2
Withdrawn1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
31
Active
2
Success Rate
91.7%
Most Advanced
Phase 3

Trials by Phase

Phase 115 (51.7%)
Phase 28 (27.6%)
Phase 32 (6.9%)
N/A4 (13.8%)

Trials by Status

withdrawn13%
completed1135%
recruiting26%
terminated13%
unknown1548%
not_yet_recruiting13%

Recent Activity

Clinical Trials (31)

Showing 20 of 31 trialsScroll for more
NCT06986070Phase 1

Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Recruiting
NCT07005687Not Applicable

Using MSCs for Chronic Active Antibody Mediated Rejection

Not Yet Recruiting
NCT01625351Phase 1

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Completed
NCT06841328

Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes

Recruiting
NCT04776538Phase 2

Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients

Unknown
NCT03308006Phase 2

Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical Trial

Completed
NCT02025270Phase 1

MSCs For Treatment of Azoospermic Patients

Completed
NCT01877837Phase 3

Stem Cell Transplantation for Sickle Cell Anemia

Completed
NCT05305833Phase 1

Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease

Unknown
NCT04972890Phase 2

The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction

Unknown
NCT00282646Phase 2

Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Completed
NCT04706312Phase 1

Transplantation of hAMSCs for Woman With DOR

Unknown
NCT04653077Not Applicable

MSCs Therapy for Cerebral Palsy

Unknown
NCT04393415Not Applicable

Using PRP and Cord Blood in Treatment of Covid -19

Unknown
NCT03067831Phase 1

Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

Unknown
NCT02638714Phase 1

Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells

Unknown
NCT01663116Phase 1

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Completed
NCT03295292Phase 1

Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze

Unknown
NCT01702961Not Applicable

Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease

Completed
NCT03067857Phase 1

Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

Unknown

Drug Details

Intervention Type
OTHER
Total Trials
31